IL2RA and myeloid sarcoma: In addition, higher relative count of CD25++CD8+ T cell in T cell was also found to decrease the risk of MS (OR [95%CI] = 0.68[0.57,0.81], P = 2.22E-05, P adjust = 1.72E-03).